Danaher Corp
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Consolidated Nonrecurring Revenue (Nonrecurring Revenue by Quarter
Consolidated Nonrecurring Revenue (Nonrecurring Revenue — Laboratory/Hospital Equipment Systems and Machinery) ($M)
Danaher Consolidated Nonrecurring Revenue (Nonrecurring Revenue: $1,155M in Q3 2026, up 11.5% from a year earlier.
Where the Q3 2026 figure comes from
Source: Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗
2-dimensional revenue breakdown in Revenue Disclosures (Note 3 / Note 6, continuing operations basis following the Veralto spin-off); Q4 is calculated as Full Year (10-K) minus 9-month (10-Q Q3).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up consolidated Nonrecurring Revenue (Nonrecurring Revenue
- Biotechnology — Nonrecurring Equipment Revenue (Nonrecurring)223 · Q3 2026
- Life Sciences — Nonrecurring Equipment Revenue (Nonrecurring: SCIEX Mass Spectrometers, Leica Microscopes, Beckman Instruments)583 · Q3 2026
- Diagnostics — Nonrecurring Equipment Revenue (Nonrecurring: Outright Diagnostic Instrument Sales)349 · Q3 2026
Cite this data
StockData. (2026). Danaher Consolidated Nonrecurring Revenue (Nonrecurring Revenue ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/disagg-total-type-nonrecurring
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.